Skip to main content
Top
Gepubliceerd in: Quality of Life Research 10/2012

01-12-2012

The impact of a recent relapse on patient-reported outcomes in subjects with multiple sclerosis

Auteurs: Brian C. Healy, Irene R. Degano, Ana Schreck, David Rintell, Howard Weiner, Tanuja Chitnis, Bonnie I. Glanz

Gepubliceerd in: Quality of Life Research | Uitgave 10/2012

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

In this study, we estimate the impact of a recent relapse on physical and mental health in subjects with relapsing-remitting multiple sclerosis (RRMS) using validated patient-reported outcome (PRO) measures.

Methods

Subjects enrolled in the Comprehensive Longitudinal Investigation of MS at the Brigham and Women’s Hospital with RRMS were eligible for enrollment. Subjects with a clinical visit within 45 days of a relapse were identified and divided into groups based on whether the relapse occurred before (recent relapse) (n = 59) or after the visit (pre-relapse) (n = 31). A group of subjects with no relapses was also identified (remission) (n = 336). PRO measures in these three groups were compared. All outcomes were compared using a t test and linear regression controlling for age, disease duration, sex, and EDSS.

Results

Subjects with a recent relapse had significantly worse functioning on several physical and mental health scales compared to subjects in remission even after adjusting for potential confounders. Subjects with a recent relapse also showed significant deterioration on PRO measures over 1 year compared to subjects in remission (P < 0.05 for each comparison). Subjects in the pre-relapse group were not significantly different than subjects in remission.

Conclusions

Clinical relapses have a measurable effect on PRO in subjects with RRMS.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Hemmett, L., Holmes, J., Barnes, M., & Russell, N. (2004). What drives quality of life in multiple sclerosis? QJM, 97(10), 671–676.PubMedCrossRef Hemmett, L., Holmes, J., Barnes, M., & Russell, N. (2004). What drives quality of life in multiple sclerosis? QJM, 97(10), 671–676.PubMedCrossRef
2.
go back to reference Nortvedt, M. W., Riise, T., Myhr, K. M., & Nyland, H. I. (1999). Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology, 53(5), 1098–1103.PubMedCrossRef Nortvedt, M. W., Riise, T., Myhr, K. M., & Nyland, H. I. (1999). Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology, 53(5), 1098–1103.PubMedCrossRef
3.
go back to reference Hermann, B. P., Vickrey, B., Hays, R. D., Cramer, J., Devinsky, O., Meador, K., et al. (1996). A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Research, 25(2), 113–118.PubMedCrossRef Hermann, B. P., Vickrey, B., Hays, R. D., Cramer, J., Devinsky, O., Meador, K., et al. (1996). A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Research, 25(2), 113–118.PubMedCrossRef
4.
go back to reference Hviid, L. E., Healy, B. C., Rintell, D. J., Chitnis, T., Weiner, H. L., & Glanz, B. I. (2011). Patient reported outcomes in benign multiple sclerosis. Multiple Sclerosis, 17(7), 876–884.PubMedCrossRef Hviid, L. E., Healy, B. C., Rintell, D. J., Chitnis, T., Weiner, H. L., & Glanz, B. I. (2011). Patient reported outcomes in benign multiple sclerosis. Multiple Sclerosis, 17(7), 876–884.PubMedCrossRef
5.
go back to reference Ford, H. L., Gerry, E., Johnson, M. H., & Tennant, A. (2001). Health status and quality of life of people with multiple sclerosis. Disability and Rehabilitation, 23(12), 516–521.PubMedCrossRef Ford, H. L., Gerry, E., Johnson, M. H., & Tennant, A. (2001). Health status and quality of life of people with multiple sclerosis. Disability and Rehabilitation, 23(12), 516–521.PubMedCrossRef
6.
go back to reference Pittock, S. J., Mayr, W. T., McClelland, R. L., Jorgensen, N. W., Weigand, S. D., Noseworthy, J. H., et al. (2004). Quality of life is favorable for most patients with multiple sclerosis: A population-based cohort study. Archives of Neurology, 61(5), 679–686.PubMedCrossRef Pittock, S. J., Mayr, W. T., McClelland, R. L., Jorgensen, N. W., Weigand, S. D., Noseworthy, J. H., et al. (2004). Quality of life is favorable for most patients with multiple sclerosis: A population-based cohort study. Archives of Neurology, 61(5), 679–686.PubMedCrossRef
7.
go back to reference Pfennings, L., Cohen, L., Ader, H., Polman, C., Lankhorst, G., Smits, R., et al. (1999). Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. Journal of Neurology, 246(7), 587–591.PubMedCrossRef Pfennings, L., Cohen, L., Ader, H., Polman, C., Lankhorst, G., Smits, R., et al. (1999). Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. Journal of Neurology, 246(7), 587–591.PubMedCrossRef
8.
go back to reference Rudick, R. A., Miller, D., Hass, S., Hutchinson, M., Calabresi, P. A., Confavreux, C., et al. (2007). Health-related quality of life in multiple sclerosis: Effects of natalizumab. Annals of Neurology, 62(4), 335–346.PubMedCrossRef Rudick, R. A., Miller, D., Hass, S., Hutchinson, M., Calabresi, P. A., Confavreux, C., et al. (2007). Health-related quality of life in multiple sclerosis: Effects of natalizumab. Annals of Neurology, 62(4), 335–346.PubMedCrossRef
9.
go back to reference Lublin, F. D., Baier, M., & Cutter, G. (2003). Effect of relapses on development of residual deficit in multiple sclerosis. Neurology, 61(11), 1528–1532.PubMedCrossRef Lublin, F. D., Baier, M., & Cutter, G. (2003). Effect of relapses on development of residual deficit in multiple sclerosis. Neurology, 61(11), 1528–1532.PubMedCrossRef
10.
go back to reference Kalb, R. (2007). The emotional and psychological impact of multiple sclerosis relapses. Journal of the Neurological Sciences, 256(Suppl 1), S29–S33.PubMedCrossRef Kalb, R. (2007). The emotional and psychological impact of multiple sclerosis relapses. Journal of the Neurological Sciences, 256(Suppl 1), S29–S33.PubMedCrossRef
11.
go back to reference Halper, J. (2007). The psychosocial effect of multiple sclerosis: The impact of relapses. Journal of the Neurological Sciences, 256(Suppl 1), S34–S38.PubMedCrossRef Halper, J. (2007). The psychosocial effect of multiple sclerosis: The impact of relapses. Journal of the Neurological Sciences, 256(Suppl 1), S34–S38.PubMedCrossRef
12.
go back to reference Orme, M., Kerrigan, J., Tyas, D., Russell, N., & Nixon, R. (2007). The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK. Value in Health, 10(1), 54–60.PubMedCrossRef Orme, M., Kerrigan, J., Tyas, D., Russell, N., & Nixon, R. (2007). The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK. Value in Health, 10(1), 54–60.PubMedCrossRef
13.
go back to reference Parkin, D., Jacoby, A., McNamee, P., Miller, P., Thomas, S., & Bates, D. (2000). Treatment of multiple sclerosis with interferon beta: An appraisal of cost-effectiveness and quality of life. Journal of Neurology, Neurosurgery and Psychiatry, 68(2), 144–149.CrossRef Parkin, D., Jacoby, A., McNamee, P., Miller, P., Thomas, S., & Bates, D. (2000). Treatment of multiple sclerosis with interferon beta: An appraisal of cost-effectiveness and quality of life. Journal of Neurology, Neurosurgery and Psychiatry, 68(2), 144–149.CrossRef
14.
go back to reference Bethoux, F., Miller, D. M., & Kinkel, R. P. (2001). Recovery following acute exacerbations of multiple sclerosis: From impairment to quality of life. Multiple Sclerosis, 7(2), 137–142.PubMed Bethoux, F., Miller, D. M., & Kinkel, R. P. (2001). Recovery following acute exacerbations of multiple sclerosis: From impairment to quality of life. Multiple Sclerosis, 7(2), 137–142.PubMed
15.
go back to reference Nortvedt, M. W., Riise, T., Myhr, K. M., & Nyland, H. I. (2000). Quality of life as a predictor for change in disability in MS. Neurology, 55(1), 51–54.PubMedCrossRef Nortvedt, M. W., Riise, T., Myhr, K. M., & Nyland, H. I. (2000). Quality of life as a predictor for change in disability in MS. Neurology, 55(1), 51–54.PubMedCrossRef
16.
go back to reference Gauthier, S. A., Glanz, B. I., Mandel, M., & Weiner, H. L. (2006). A model for the comprehensive investigation of a chronic autoimmune disease: The multiple sclerosis CLIMB study. Autoimmunity Reviews, 5(8), 532–536.PubMedCrossRef Gauthier, S. A., Glanz, B. I., Mandel, M., & Weiner, H. L. (2006). A model for the comprehensive investigation of a chronic autoimmune disease: The multiple sclerosis CLIMB study. Autoimmunity Reviews, 5(8), 532–536.PubMedCrossRef
17.
go back to reference Gorman, M. P., Healy, B. C., Polgar-Turcsanyi, M., & Chitnis, T. (2009). Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Archives of Neurology, 66(1), 54–59.PubMedCrossRef Gorman, M. P., Healy, B. C., Polgar-Turcsanyi, M., & Chitnis, T. (2009). Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Archives of Neurology, 66(1), 54–59.PubMedCrossRef
18.
go back to reference Ware, J. E., Jr, & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.PubMedCrossRef Ware, J. E., Jr, & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.PubMedCrossRef
19.
go back to reference Radloff, L. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.CrossRef Radloff, L. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.CrossRef
20.
go back to reference Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J., & Murray, T. J. (1994). The impact of fatigue on patients with multiple sclerosis. Canadian Journal of Neurological Sciences, 21(1), 9–14.PubMed Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J., & Murray, T. J. (1994). The impact of fatigue on patients with multiple sclerosis. Canadian Journal of Neurological Sciences, 21(1), 9–14.PubMed
21.
go back to reference Ritvo, P., Fischer, J., Miller, D., Paty, D., & LaRocca, N. (1997). Multiple sclerosis quality of life inventory: A user’s manual. New York, NY: National Multiple Sclerosis Society. Ritvo, P., Fischer, J., Miller, D., Paty, D., & LaRocca, N. (1997). Multiple sclerosis quality of life inventory: A user’s manual. New York, NY: National Multiple Sclerosis Society.
22.
go back to reference Efron, B., & Tibshirani, R. (1993). An introduction to the bootstrap. New York, NY: Chapman & Hall. Efron, B., & Tibshirani, R. (1993). An introduction to the bootstrap. New York, NY: Chapman & Hall.
23.
go back to reference Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592.PubMed Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592.PubMed
24.
go back to reference Freedman, M. S., Patry, D. G., Grand’Maison, F., Myles, M. L., Paty, D. W., & Selchen, D. H. (2004). Treatment optimization in multiple sclerosis. Canadian Journal of Neurological Sciences, 31(2), 157–168.PubMed Freedman, M. S., Patry, D. G., Grand’Maison, F., Myles, M. L., Paty, D. W., & Selchen, D. H. (2004). Treatment optimization in multiple sclerosis. Canadian Journal of Neurological Sciences, 31(2), 157–168.PubMed
Metagegevens
Titel
The impact of a recent relapse on patient-reported outcomes in subjects with multiple sclerosis
Auteurs
Brian C. Healy
Irene R. Degano
Ana Schreck
David Rintell
Howard Weiner
Tanuja Chitnis
Bonnie I. Glanz
Publicatiedatum
01-12-2012
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 10/2012
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-011-0108-0

Andere artikelen Uitgave 10/2012

Quality of Life Research 10/2012 Naar de uitgave